CARsgen Therapeutics competitorsClear all

CARsgen Therapeutics's top competitors include ANKAA THERAPEUTICS, Cybrexa Therapeutics, Numab and OncoTherapy Science.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
CARsgen Therapeutics
CARsgen Therapeutics
CARsgen Therapeutics is a clinical-stage immune-oncology company that develops a new chimeric T-cell antigen receptor for liver, lung, stomach and brain cancers treatment.
ANKAA THERAPEUTICS
ANKAA THERAPEUTICS
Ankaa Therapeutics is a company providing targeted small molecule drugs for personalized therapy.
Cybrexa Therapeutics
Cybrexa Therapeutics
Cybrexa Therapeutics is a biotechnology company developing cancer therapeutics.
Numab
Numab
Numab Therapeutics is an oncology-focused biopharmaceutical company.
OncoTherapy Science
OncoTherapy Science
OncoTherapy Science is a company engaged in research and development of cancer therapeutics.
Founding Date
Founding Date
2014
Founding Date
N/A
Founding Date
2016
Founding Date
2011
Founding Date
2001
Type
Type
Private
Type
Private
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Shanghai, CN HQ
Beijing, CN
Shanghai, CN
Shanghai, CN
Bellaire, US
Locations
HQ
Locations
New Haven, US HQ
Locations
Wädenswil, CH HQ
Locations
Kawasaki, JP HQ
Employees
Employees
766% increase
Employees
N/A
Employees
215% decrease
Employees
479% increase
Employees
666% increase
Twitter followers
Twitter followers
84
Twitter followers
N/A
Twitter followers
143
Twitter followers
106
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1
Average likes per tweet (last 30 days)
1.5
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
584252
Alexa Website Rank
N/A
Alexa Website Rank
437830
Alexa Website Rank
N/A
Alexa Website Rank
201016
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
3.1
Employee Rating
N/A

Funding

Latest funding round
Latest funding round
$ 186m (about 1 year ago)
Latest funding round
N/A
Latest funding round
$ 25m (9 months ago)
Latest funding round
$ 110m (7 months ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 276m
Total funding raised
N/A
Total funding raised
$ 44.4m
Total funding raised
$ 132.3m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

ANKAA THERAPEUTICS
HQ

Ankaa Therapeutics is a company providing targeted small molecule drugs for personalized therapy.

View company
Cybrexa Therapeutics
HQ
New Haven, US
Employees
21↓ 5% decrease

Cybrexa Therapeutics is a biotechnology company developing cancer therapeutics.

View company
Numab
HQ
Wädenswil, CH
Employees
47↑ 9% increase

Numab Therapeutics is an oncology-focused biopharmaceutical company.

View company
OncoTherapy Science
HQ
Kawasaki, JP
Employees
66↑ 6% increase

OncoTherapy Science is a company engaged in research and development of cancer therapeutics.

View company